Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data

被引:0
|
作者
Hong Ki Min [1 ]
Se Hee Kim [1 ]
Jong Han Choi [1 ]
Kyomin Choi [2 ]
Hae-Rim Kim [3 ]
Sang-Heon Lee [3 ]
机构
[1] Department of Internal Medicine, Konkuk University Medical Center
[2] Department of Neurology, Konkuk University Medical Center
[3] Division of Rheumatology, Department of Internal Medicine,Konkuk University School of Medicine
关键词
D O I
暂无
中图分类号
R587.2 [糖尿病性昏迷及其他并发症];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Neuropathy is a common chronic complication in type 2 diabetes mellitus(T2DM). Statin and metformin are commonly used medications in T2DM patients, and some studies showed statin-or metformin-induced neuropathy.AIM To evaluate the incidence of neuropathy among patients with T2DM associated with statin and metformin therapies.METHODS Korean Health Insurance Review and Assessment national patient sample data from 2016 and 2017 were used. Patients with T2 DM and no complications were divided into statin/metformin/statin + metformin users and non-users. Neuropathy incidence was defined by International Statistical Classification of Diseases and Related Health Problems, 10 th revision codes and concomitant prescriptions for anticonvulsants or antidepressants. Logistic regression analyses were conducted to examine the associations between statin/metformin/statin + metformin therapies and the incidence of neuropathy. Propensity score(PS) matching was performed on the basis of age, sex and comorbidities.RESULTS Overall, 34964 and 35887 patients with T2DM and no complications were included in the Korean Health Insurance Review and Assessment national patient sample datasets from 2016 and 2017, respectively. Statin therapy was associated with increased risks of neuropathy in 2016 and 2017 [PS-matched odds ratio(OR) = 1.22, 95% confidence interval(CI): 1.08-1.38; PS-matched OR = 1.17, 95%CI: 1.03-1.33, respectively]. Metformin therapy was associated with reduced risks of neuropathy in 2016 and 2017(PS-matched OR = 0.30, 95%CI: 0.21-0.42; PSmatched OR = 0.44, 95%CI: 0.32-0.60, respectively). Combined statin + metformin therapy was not significantly associated with neuropathy in 2016 or 2017(PSmatched OR = 0.85, 95%CI: 0.61-1.19; PS-matched OR = 0.95, 95%CI: 0.66-1.38, respectively).CONCLUSION Statin therapy was associated with enhanced risk of new-onset neuropathy in patients with T2DM, but metformin therapy showed the opposite association.
引用
收藏
页码:10198 / 10207
页数:10
相关论文
共 50 条
  • [1] Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data
    Min, Hong Ki
    Kim, Se Hee
    Choi, Jong Han
    Choi, Kyomin
    Kim, Hae-Rim
    Lee, Sang-Heon
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (33) : 10198 - 10207
  • [2] Clinical Characteristics According to the Use of Metformin in Korean Patients with Type 2 Diabetes Mellitus
    Ha, In Gyoon
    Rhee, Sang Youl
    Han, Seoung Woo
    Cho, Sung Kweon
    Chon, Suk
    Kim, Sung Hoon
    Ahn, Kyu Jeung
    Baik, Sei Hyun
    Park, Yongsoo
    Nam, Moon Suk
    Lee, Kwan Woo
    Woo, Jeong Taek
    Kim, Young Seol
    DIABETES, 2017, 66 : A324 - A324
  • [3] Factors associated with type 2 diabetes mellitus development based on Korean national health insurance sharing service data
    Kim, Jun Hyeob
    Min, Kyung Hyun
    Gil, Jin Yeon
    Lee, Kyung Eun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 248 - 248
  • [5] Metformin treatment and risk of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus in Beijing, China
    Yang, Ruotong
    Yu, Huan
    Wu, Junhui
    Chen, Hongbo
    Wang, Mengying
    Wang, Siyue
    Qin, Xueying
    Wu, Tao
    Wu, Yiqun
    Hu, Yonghua
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [6] EFFECT OF GENETICPOLYMORPHISM OF OCT AND MATE TRANSPORTERS ON METFORMIN RESPONSE IN KOREAN TYPE 2 DIABETES MELLITUS PATIENTS
    Park, Jeong-eun
    Choi, Jee-hye
    Kim, Tae-eun
    Kwon, Hyeog-jung
    Shin, Kwang-Hee
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S86 - S86
  • [7] Metformin for Type 2 diabetes mellitus
    MacDonald, Blair J.
    Turgeon, Ricky D.
    McCormack, James
    ACADEMIC EMERGENCY MEDICINE, 2024, 31 (08) : 832 - 834
  • [8] Diabetic peripheral neuropathy is highly associated with nontraumatic fractures in Korean patients with type 2 diabetes mellitus
    Kim, Ji-Hyun
    Jung, Mi-Hyang
    Lee, Jung-Min
    Son, Hyun-Shik
    Cha, Bong-Yun
    Chang, Sang-Ah
    CLINICAL ENDOCRINOLOGY, 2012, 77 (01) : 51 - 55
  • [9] The Relationship between Diabetic Peripheral Neuropathy and Metformin Treatment in Type 2 Diabetes Mellitus
    Pan, Qi
    Luo, Jingyi
    Guo, Lixin
    DIABETES, 2022, 71
  • [10] Cobalamin status and its relation with depression, cognition and neuropathy in patients with type 2 diabetes mellitus using metformin
    Elke Biemans
    Huberta E. Hart
    Guy E. H. M. Rutten
    Viviana G. Cuellar Renteria
    Antoinette M. J. Kooijman-Buiting
    Joline W. J. Beulens
    Acta Diabetologica, 2015, 52 : 383 - 393